Search jobs 04-Feb-2021 Bioimpedance Devices Market Analysis and In-depth study on Market Size Trends, Emerging Growth Factors and Regional Forecast to 2028
VALLEY COTTAGE, N.Y. – A recent market study published by FMI titled “
Bioimpedance Devices Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018–2028” consists of a comprehensive assessment of the most important market dynamics. Following thorough research on the historic as well as current growth parameters of the bioimpedance devices market, growth prospects for the market have been obtained with maximum precision. The bioimpedance devices market report features unique and salient factors that are expected to significantly impact the development of the bioimpedance devices market during the forecast period.
[BENGALURU] European shares rose on Tuesday on hopes of a faster economic recovery, with some upbeat economic growth data and encouraging outlook on big names such as Airbus and LVMH putting a pan-regional index on course to erase last week's hefty losses. Read more at The Business Times.
Company
Fresenius Medical Care AG & Co. KGaA is the world s leading supplier of services and equipment for patients with kidney problems. Net sales break down by activity as follows:
- clinical care services (79.4%): operated, at the end of 2019, 3,994 institutions;
- manufacturing of dialyzers and related products (20.6%): hemo-dialysis and pediatric dialysis machines, etc. The group also offers therapies accompanied by.
BAD HOMBURG VOR DER HOEHE (dpa-AFX) - Fresenius SE & Co. KgaA targets healthy sales growth in constant currency and at least broadly stable net income year-over-year in fiscal year 2021.The company